Guangbing Li

807 total citations
32 papers, 496 citations indexed

About

Guangbing Li is a scholar working on Molecular Biology, Surgery and Cancer Research. According to data from OpenAlex, Guangbing Li has authored 32 papers receiving a total of 496 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 13 papers in Surgery and 10 papers in Cancer Research. Recurrent topics in Guangbing Li's work include Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers), Gallbladder and Bile Duct Disorders (5 papers) and Cancer-related molecular mechanisms research (5 papers). Guangbing Li is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers), Gallbladder and Bile Duct Disorders (5 papers) and Cancer-related molecular mechanisms research (5 papers). Guangbing Li collaborates with scholars based in China, United States and Australia. Guangbing Li's co-authors include Jun Liu, Haitao Zhao, Ruoyu Miao, Xiaobo Yang, Junjie Kong, Xueshuai Wan, Anqiang Wang, Chengpei Zhu, Shuguang Chen and Lian He and has published in prestigious journals such as The Science of The Total Environment, Hepatology and International Journal of Molecular Sciences.

In The Last Decade

Guangbing Li

30 papers receiving 492 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guangbing Li China 13 223 201 100 96 95 32 496
Tianying Zheng China 14 167 0.7× 84 0.4× 154 1.5× 84 0.9× 55 0.6× 33 556
Maja Katrin Tietze Germany 8 275 1.2× 106 0.5× 84 0.8× 81 0.8× 138 1.5× 9 622
Meng‐chao Wang China 11 303 1.4× 267 1.3× 149 1.5× 125 1.3× 41 0.4× 12 515
Chong Zhou China 13 210 0.9× 131 0.7× 33 0.3× 55 0.6× 38 0.4× 26 523
Özgür Cem Erkin Türkiye 9 211 0.9× 84 0.4× 66 0.7× 24 0.3× 52 0.5× 18 429
Jingchao Xu China 14 440 2.0× 373 1.9× 54 0.5× 52 0.5× 44 0.5× 20 703
Huijuan Dai China 12 201 0.9× 120 0.6× 83 0.8× 58 0.6× 125 1.3× 26 518
Yang Wen China 12 456 2.0× 358 1.8× 42 0.4× 62 0.6× 32 0.3× 30 735
Jin‐Mei Piao China 15 217 1.0× 89 0.4× 26 0.3× 52 0.5× 94 1.0× 26 494

Countries citing papers authored by Guangbing Li

Since Specialization
Citations

This map shows the geographic impact of Guangbing Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guangbing Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guangbing Li more than expected).

Fields of papers citing papers by Guangbing Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guangbing Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guangbing Li. The network helps show where Guangbing Li may publish in the future.

Co-authorship network of co-authors of Guangbing Li

This figure shows the co-authorship network connecting the top 25 collaborators of Guangbing Li. A scholar is included among the top collaborators of Guangbing Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guangbing Li. Guangbing Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Li, Yongsheng, Jing Wu, Jihua Wang, et al.. (2025). Cost-effectiveness analysis of pembrolizumab combined with gemcitabine and cisplatin for the first-line treatment for advanced cholangiocarcinoma. Heliyon. 11(6). e42553–e42553. 1 indexed citations
3.
Li, Guangbing, et al.. (2024). Methyl Cinnamate (MC) Alleviates Free Fatty Acids (FFAs) Induced Lipid Accumulation Through the AMPK Pathway in HepG2 Cells. Diabetes Metabolic Syndrome and Obesity. Volume 17. 1183–1197. 2 indexed citations
4.
Zhang, Yanquan, Ka-wing Fong, Fengyi Mao, et al.. (2024). Elevating PLK1 overcomes BETi resistance in prostate cancer via triggering BRD4 phosphorylation-dependent degradation in mitosis. Cell Reports. 43(7). 114431–114431. 9 indexed citations
5.
6.
Yang, Yang, Guangbing Li, Yu Zhang, Yunfeng Cui, & Jun Liu. (2023). Protein Induced by Vitamin K Absence II: A Potential Biomarker to Differentiate Pancreatic Ductal Adenocarcinoma from Pancreatic Benign Lesions and Predict Vascular Invasion. Journal of Clinical Medicine. 12(8). 2769–2769. 7 indexed citations
7.
Wang, Wei, Chen Wu, Peilin Li, et al.. (2023). Development and validation of a gene expression-based nomogram to predict the prognosis of patients with cholangiocarcinoma. Journal of Cancer Research and Clinical Oncology. 149(12). 9577–9586. 1 indexed citations
8.
Liu, Yong, Guangbing Li, Yang Yang, et al.. (2022). Analysis of N6-Methyladenosine Modification Patterns and Tumor Immune Microenvironment in Pancreatic Adenocarcinoma. Frontiers in Genetics. 12. 752025–752025. 4 indexed citations
9.
Kong, Junjie, Guangsheng Yu, Wei Si, et al.. (2022). Identification of a glycolysis-related gene signature for predicting prognosis in patients with hepatocellular carcinoma. BMC Cancer. 22(1). 142–142. 17 indexed citations
10.
Wang, Xiaoyu, Guangbing Li, Jingyi He, et al.. (2021). COPB2: A Novel Prognostic Biomarker That Affects Progression of HCC. BioMed Research International. 2021(1). 6648078–6648078. 5 indexed citations
11.
12.
Yang, Yang, Guangbing Li, Ziwen Lu, et al.. (2021). Progression of Prothrombin Induced by Vitamin K Absence-II in Hepatocellular Carcinoma. Frontiers in Oncology. 11. 726213–726213. 32 indexed citations
13.
Wang, Liuwei, et al.. (2021). Long-term immobilization of soil metalloids under simulated aging: Experimental and modeling approach. The Science of The Total Environment. 806(Pt 1). 150501–150501. 37 indexed citations
14.
Liu, Yong, Guangbing Li, Ziwen Lu, et al.. (2021). Effect of vascular resection for perihilar cholangiocarcinoma: a systematic review and meta-analysis. PeerJ. 9. e12184–e12184. 2 indexed citations
15.
He, Jingyi, Guangbing Li, Xihan Liu, et al.. (2020). Diagnostic and Prognostic Values of MANF Expression in Hepatocellular Carcinoma. BioMed Research International. 2020(1). 1936385–1936385. 14 indexed citations
16.
Li, Guangbing, et al.. (2020). The association between genomic variations and histological grade in hepatocellular carcinoma. Translational Cancer Research. 9(4). 2424–2433. 4 indexed citations
17.
18.
Hou, Xu, Le Yang, Xiaohong Jiang, et al.. (2019). Role of microRNA-141-3p in the progression and metastasis of hepatocellular carcinoma cell. International Journal of Biological Macromolecules. 128. 331–339. 36 indexed citations
19.
Zhang, Lingling, Leiming Liu, Zhiyong He, et al.. (2015). Inhibition of wild‐type p53‐induced phosphatase 1 promotes liver regeneration in mice by direct activation of mammalian target of rapamycin. Hepatology. 61(6). 2030–2041. 30 indexed citations
20.
Liu, Jing, et al.. (2014). FH535 inhibits the proliferation of HepG2 cells via downregulation of the Wnt/β-catenin signaling pathway. Molecular Medicine Reports. 9(4). 1289–1292. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tianying Zheng Breakdown of academic impact, for papers by Maja Katrin Tietze Breakdown of academic impact, for papers by Meng‐chao Wang Breakdown of academic impact, for papers by Chong Zhou Breakdown of academic impact, for papers by Özgür Cem Erkin Breakdown of academic impact, for papers by Jingchao Xu Breakdown of academic impact, for papers by Huijuan Dai Breakdown of academic impact, for papers by Yang Wen Breakdown of academic impact, for papers by Jin‐Mei Piao
Rankless by CCL
2026